Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800
Debt
Debt-to-Equity Ratio0.16
Current Ratio1.41
Quick Ratio1.41
Price-To-Earnings
Trailing P/E Ratio91.86
Forward P/E Ratio98.82
P/E Growth4.87
Sales & Book Value
Annual Sales$545.53 million
Price / Sales8.54
Cash Flow$1.5620 per share
Price / Cash49.98
Book Value$8.51 per share
Price / Book9.17
Profitability
EPS (Most Recent Fiscal Year)$0.85
Net Income$44.38 million
Net Margins9.13%
Return on Equity11.37%
Return on Assets5.63%
Miscellaneous
Employees1,680
Outstanding Shares59,680,000
Market Cap$4.63 billion
Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions
What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
How were Medidata Solutions' earnings last quarter?
Medidata Solutions Inc (NASDAQ:MDSO) posted its quarterly earnings data on Tuesday, July, 24th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.04. The firm had revenue of $155.90 million for the quarter, compared to analysts' expectations of $155.86 million. Medidata Solutions had a net margin of 9.13% and a return on equity of 11.37%. The company's quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.31 EPS. View Medidata Solutions' Earnings History.
When is Medidata Solutions' next earnings date?
What price target have analysts set for MDSO?
13 Wall Street analysts have issued 12-month price objectives for Medidata Solutions' shares. Their predictions range from $78.00 to $98.00. On average, they expect Medidata Solutions' stock price to reach $87.9231 in the next year. This suggests a possible upside of 13.4% from the stock's current price. View Analyst Price Targets for Medidata Solutions.
What is the consensus analysts' recommendation for Medidata Solutions?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medidata Solutions.
Who are some of Medidata Solutions' key competitors?
Some companies that are related to Medidata Solutions include CA (CA), Shopify (SHOP), Splunk (SPLK), Citrix Systems (CTXS), TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO), ANSYS (ANSS), Mobileye (MBBYF), Synopsys (SNPS), SS&C Technologies (SSNC), Cadence Design Systems (CDNS), Dropbox (DBX), UBISOFT Entmt S/ADR (UBSFY), Veeva Systems (VEEV), Symantec (SYMC) and PTC (PTC).
Who are Medidata Solutions' key executives?
Medidata Solutions' management team includes the folowing people:
- Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 56)
- Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 46)
- Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 45)
- Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 47)
- Mr. Michael Pray, Exec. VP & GM of Global Sales (Age 52)
Has Medidata Solutions been receiving favorable news coverage?
Headlines about MDSO stock have trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medidata Solutions earned a news impact score of 0.21 on Accern's scale. They also assigned news stories about the company an impact score of 46.69 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Medidata Solutions.
Who are Medidata Solutions' major shareholders?
Medidata Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (3.19%), American Century Companies Inc. (2.50%), Global Thematic Partners LLC (2.24%), Canada Pension Plan Investment Board (1.86%), Fred Alger Management Inc. (1.80%) and Disciplined Growth Investors Inc. MN (1.55%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Eileen Schloss, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.
Which major investors are selling Medidata Solutions stock?
MDSO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Brown Advisory Inc., Voya Investment Management LLC, ARK Investment Management LLC, Eagle Asset Management Inc., Global Thematic Partners LLC, Peregrine Capital Management LLC and Advisors Asset Management Inc.. Company insiders that have sold Medidata Solutions company stock in the last year include Carlos Dominguez, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions.
Which major investors are buying Medidata Solutions stock?
MDSO stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Fred Alger Management Inc., Ownership Capital B.V., Copper Rock Capital Partners LLC, Frontier Capital Management Co. LLC, Rice Hall James & Associates LLC, Royce & Associates LP and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Medidata Solutions.
How do I buy shares of Medidata Solutions?
Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medidata Solutions' stock price today?
One share of MDSO stock can currently be purchased for approximately $77.52.
How big of a company is Medidata Solutions?
Medidata Solutions has a market capitalization of $4.63 billion and generates $545.53 million in revenue each year. The company earns $44.38 million in net income (profit) each year or $0.85 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.
How can I contact Medidata Solutions?
Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]
MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
